Cargando…

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

BACKGROUND: With the phase-out of stavudine (d4T), change to first-line regimens with zidovudine (AZT) or tenofovir (TDF) in resource-limited settings (RLS) might increase risks of cross-resistance to nucleos(t) ide reverse transcriptase inhibitors (NRTI). This would restrict the scope of switching...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takou, Desire, Fokam, Joseph, Teto, Georges, Santoro, Maria-Mercedes, Ceccherini-Silberstein, Francesca, Nanfack, Aubin Joseph, Sosso, Samuel Martin, Dambaya, Béatrice, Salpini, Romina, Billong, Serge Clotaire, Gori, Caterina, Fokunang, Charles Ntungwen, Cappelli, Giulia, Colizzi, Vittorio, Perno, Carlo-Federico, Ndjolo, Alexis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419466/ https://www.ncbi.nlm.nih.gov/pubmed/30871487 http://dx.doi.org/10.1186/s12879-019-3871-0

Ejemplares similares

Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023)

Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon
por: Fokam, Joseph, et al.
Publicado: (2020)

Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé
por: Nka, Alex Durand, et al.
Publicado: (2019)

Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens
por: Fokam, Joseph, et al.
Publicado: (2023)

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens
por: Fokam, Joseph, et al.
Publicado: (2020)

Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients
por: Teto, Georges, et al.
Publicado: (2022)

Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children
por: Fokam, Joseph, et al.
Publicado: (2018)

HIV-1 Gag gene mutations, treatment response and drug resistance to protease inhibitors: A systematic review and meta-analysis protocol
por: Nka, Alex Durand, et al.
Publicado: (2021)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol
por: Semengue, Ezechiel Ngoufack Jagni, et al.
Publicado: (2020)

Differential expression of Fas receptors (CD95) and Fas ligands (CD95L) in HIV infected and exposed uninfected children in Cameroon versus unexposed children
por: Dambaya, Béatrice, et al.
Publicado: (2019)

Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model
por: Semengue, Ezechiel Ngoufack Jagni, et al.
Publicado: (2022)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis
por: Ngoufack Jagni Semengue, Ezechiel, et al.
Publicado: (2022)

Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat”
por: Fokam, Joseph, et al.
Publicado: (2019)

Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study)
por: Fokam, Joseph, et al.
Publicado: (2019)

Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings
por: Fokam, Joseph, et al.
Publicado: (2022)

Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era
por: PABO, WILLY LE ROI TOGNA, et al.
Publicado: (2023)

Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon
por: Fokam, Joseph, et al.
Publicado: (2020)

Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000)
por: Fokam, Joseph, et al.
Publicado: (2022)

Lipid Peroxidation and Total Cholesterol in HAART-Naïve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon
por: Teto, Georges, et al.
Publicado: (2013)

Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling
por: Billong, Serge Clotaire, et al.
Publicado: (2016)

Determinants of periodontitis according to the immunological and virological profiles of HIV-infected patients in Yaoundé, Cameroon
por: Fokam, Joseph, et al.
Publicado: (2020)

Characterization of the Viral Reservoirs Among HIV-1 Non-B Vertically Infected Adolescents Receiving Antiretroviral Therapy: Protocol for an Observational and Comparative Study in Cameroon
por: Nanfack, Aubin Joseph, et al.
Publicado: (2022)

HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon
por: Mbouyap, Pretty Rosereine, et al.
Publicado: (2023)

High genotypic diversity of human papillomavirus among women in Cameroon: implications for vaccine effectiveness
por: Tchouaket, Michel Carlos Tommo, et al.
Publicado: (2022)

Characterisation of HIV-1 reservoirs in paediatric populations: protocol for a systematic review and meta-analysis
por: Ka’e, Aude Christelle, et al.
Publicado: (2023)

Challenges faced by the HIV testing system in low- and middle-income countries
por: Kamgaing, Rachel S., et al.
Publicado: (2023)

HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study
por: Togna Pabo, Willy Le roi, et al.
Publicado: (2023)

Using weight-for-age for predicting wasted children in Cameroon
por: Nguefack-Tsague, Georges, et al.
Publicado: (2013)

Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies
por: Ka’e, Aude Christelle, et al.
Publicado: (2023)

The declining trend of HIV-Infection among pregnant women in Cameroon infers an epidemic decline in the general population
por: Billong, Serge-Clotaire, et al.
Publicado: (2020)

COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde: Lessons from the early phase of the pandemic in Cameroon
por: Fokam, Joseph, et al.
Publicado: (2023)

Alteration of the gut fecal microbiome in children living with HIV on antiretroviral therapy in Yaounde, Cameroon
por: Abange, William Baiye, et al.
Publicado: (2021)

Feasibility Study of HIV Sentinel Surveillance using PMTCT data in Cameroon: from Scientific Success to Programmatic Failure
por: Billong, Serge C., et al.
Publicado: (2017)

High concordance in SARSCoV-2 detection between automated (Abbott m2000) and manual (DaAn gene) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon
por: Fainguem, Nadine Nguendjoung, et al.
Publicado: (2022)

Prevalence and risk factors to HIV-infection amongst health care workers within public and private health facilities in Cameroon
por: Domkam, Irénée Kammogne, et al.
Publicado: (2018)

Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000
por: Fokam, Joseph, et al.
Publicado: (2022)

Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol
por: Nka, Alex Durand, et al.
Publicado: (2022)

Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon
por: Fokam, Joseph, et al.
Publicado: (2017)

TRIM5α 136Q, CCR5 Promoter 59029G And CCR264I Alleles Impact The Progression Of HIV In Children And Adolescents
por: Dambaya, Béatrice, et al.
Publicado: (2019)

Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings
por: Dobseu, Rodolphe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9d26ha1nlos1r4o8ditumgpqdn